Revive Therapeutics Engages NYU School of Medicine for Cystinuria Phase 2 Study
TORONTO, ONTARIO--(Marketwired - Dec 21, 2016) - Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE:RVV)(OTCQB:RVVTF), a company focused on commercializing treatments for rare diseases such as Cystinuria and Wilson's …